Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Delayed-Release Metformin in Renal Dysfunction
NCT01658514Phase 2Completed
- Sponsor
- Elcelyx Therapeutics
- Start
- Jan 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of metformin delayed release in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Elcelyx Therapeutics. Primary endpoints: Area Under the Curve (0-t) of Plasma Metformin, Maximum Plasma Concentration of Metformin and 1 more. Started Jan 2014; status: completed.
02
Drugs
metformin delayed release
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01658514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01658514.